The emergence of the highly transmissible B.1.1.529 Omicron variant of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is concerning for antibody countermeasure …

The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …

At the end of 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2;
SARS-CoV-2) was detected in Wuhan, China, that spread rapidly around the world, with …

Antiviral Agents and Omicron BQ. 1.1 and XBB Neither bebtelovimab nor any mAb
combinations tested neutralized the SARS-CoV-2 omicron subvariants BQ. 1.1 and XBB, but …

The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in
the spike protein, 15 of which are in the receptor-binding domain (RBD), thereby raising …

The recent emergence of SARS-CoV-2 Omicron (B.1.1.529 lineage) variants possessing
numerous mutations has raised concerns of decreased effectiveness of current vaccines, …

… n engl j med 383;6 nejm.org August 6, 2020 … Pei G, Zhang Z, Peng J, et al. Renal
involvement and early prognosis in patients with COVID-19 pneumonia. … n engl j med 383;6 …

The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …

The BA.2 sublineage of the SARS-CoV-2 Omicron variant has become dominant in most
countries around the world; however, the prevalence of BA.4 and BA.5 is increasing rapidly in …

The SARS-CoV-2 Delta Variant of Concern is highly transmissible and contains mutations
that confer partial immune escape. The emergence of Delta in North America caused the first …